Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
about
A Systematic Review of the Relation Between Long-term Exposure to Ambient Air Pollution and Chronic DiseasesThe history of COPDNutritional supplementation for stable chronic obstructive pulmonary diseaseNutritional supplementation for stable chronic obstructive pulmonary diseaseMuscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findingsRole of autophagy in COPD skeletal muscle dysfunctionChronic obstructive pulmonary disease patients have greater systemic responsiveness to ex vivo stimulation with swine dust extract and its components versus healthy volunteersThe effects of outdoor air pollution on chronic illnessesAltered tissue distribution in adults with cystic fibrosis.Patterns of inflammation and the use of reversibility testing in smokers with airway complaintsIL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study.The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease.Maternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells To produce pro- and anti-inflammatory cytokines.Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors?Proteomic profiling of peripheral blood neutrophils identifies two inflammatory phenotypes in stable COPD patients.Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia.Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patientsHigh sensitive C-reactive protein as a systemic inflammatory marker and LDH-3 isoenzyme in chronic obstructive pulmonary disease.The mediating role of cytokine IL-6 on the relationship of FEV₁ upon 6-minute walk distance in chronic obstructive pulmonary disease.Health status measurement in chronic obstructive pulmonary disease.Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms.American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation.Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function.Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort.Body composition and mortality after adult lung transplantation in the United StatesChronic obstructive pulmonary disease. 5: systemic effects of COPDThe lung inflammation and skeletal muscle wasting induced by subchronic cigarette smoke exposure are not altered by a high-fat diet in mice.Associated bone mineral density and obstructive sleep apnea in chronic obstructive pulmonary diseaseResting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary diseaseA bibliometric analysis of the 100 most influential papers on COPDSystemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations.Time course of recovery of health status following an infective exacerbation of chronic bronchitis.Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial.Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD.Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease.
P2860
Q21651047-C893A5EB-35F5-4186-A27A-E6C7E248EAB3Q22305861-0EC65E4C-DA07-4172-8BC7-2296AB10F84EQ24202330-6CC23184-8557-483E-A43F-7C5985273081Q24244188-6AD23DE3-9005-4F20-989C-1AD9756F61E4Q26775701-EB726D0E-2A42-4F95-822B-B407FFE62255Q27015002-7EF4A930-C06A-45DB-882D-2D470E0678E6Q28384754-45841985-DFB3-489E-B2F4-90604E536362Q28767936-E546E580-0C12-4EB3-B0E8-A216E6792CDAQ31003846-FF2F43EA-82CC-4033-A1F6-C521F70353F4Q33245416-07EF993E-A66A-48A9-897A-4C9CBFC6A772Q33416183-6D0A55F2-8FB8-470F-B99C-6FA869274448Q33498530-45CDC84A-2970-422D-BA80-57610450F11DQ33600538-ADE60F2E-9E75-46F6-8433-CC7A05C39A06Q33649907-95A241C9-D3B6-4A66-9622-EFCED2ABE7E8Q33716738-7562106F-E1A6-4A7D-A057-6CA4EAB2D738Q33755791-4F5A95CF-6D91-43C0-AE2B-64D8C1D99C9EQ33880491-BDBE5675-6CA8-44E3-A292-A000EAAD2D3BQ34061404-F1D653D8-6F37-4107-AAE0-AF189B8ACF24Q34255448-F06AE179-5E45-463C-A921-4A7DAAC87A41Q34352974-A7744C3D-5382-4AA0-804C-4D35448FF3F8Q34407695-36254FD7-6AC9-4E47-8E64-CE9E316E46ECQ34446644-876BDBF2-7D7A-43CE-BF6D-F5891DB6498BQ34535807-60969DA6-3250-40E1-9AC4-C7E69B843A5BQ34625439-8C937FDF-599B-4FE9-899E-596631452D17Q34684222-8CB28E57-3EBE-4E37-B00F-535CD9741C8DQ34903298-A9B40037-E586-40B9-99A4-25E9C6947125Q34914760-0CE91490-6D75-4652-84B1-3CBF0CF89728Q34986947-4C2DCEC1-5581-4938-9904-3D0B63F50F0CQ35009945-BA889E3E-5CED-4796-881E-CA5633E6322BQ35049038-A7FF9F57-4281-4651-BFFC-129CC00C400FQ35063766-3B27C552-7C9C-4361-A2A7-425CD613B528Q35223742-C81240BE-CC3A-4864-A9EA-07B67F51E09AQ35230811-C1487982-0DC5-4FEA-89D0-AFC3FF73B396Q35534719-D03DEBC0-0677-4205-95F4-F596603C8B59Q35536058-1A72BC92-0EC5-43ED-926D-335AD1F98BB3Q35536178-4F20D25D-F4B4-48E6-AC2E-63AC24E228D6Q35536202-96E3568C-DA3F-428B-AC3B-FFFCF08C2E48Q35536791-8BB40FFD-0A92-4555-89D2-C7DB92E18993Q35563842-FACC4BDE-0B1A-412B-BE7A-D65AF612B83CQ35690112-E7EE130A-F44E-4F47-90AE-78FEA850A1FC
P2860
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Evidence for a relation betwee ...... obstructive pulmonary disease.
@en
type
label
Evidence for a relation betwee ...... obstructive pulmonary disease.
@en
prefLabel
Evidence for a relation betwee ...... obstructive pulmonary disease.
@en
P2093
P2860
P356
P1433
P1476
Evidence for a relation betwee ...... obstructive pulmonary disease.
@en
P2093
Buurman WA
Dentener MA
Staal van den Brekel AJ
Wouters EF
P2860
P304
P356
10.1136/THX.51.8.819
P407
P577
1996-08-01T00:00:00Z